CDG Capital
晨岭资本
elsewhere's corpus has essentially no profile material on CDG Capital — the entity card carries no description, and no article in the corpus is actually about the fund itself. The single data point available is a deal mention: CDG Capital appears as a follow-on investor in Mirxes' $87 million Series C round in October 2021, a round led by the CR-CP Life Science Fund alongside Rock Springs Capital, EDBI, CCB International and others . Beyond that one co-investment, elsewhere cannot say what kind of fund CDG Capital is, when it was founded, or what its strategy is — this subject simply isn't covered in the corpus.
AI-generated — may contain errors, please verify.
Coverage
3 Biopharma Companies Raise Over 1 Billion Yuan Combined | FreeS Family Funding News · October–November
Firmly bullish on the development of biomedical innovation in China
Gaorong Monthly · October | Gaorong Ventures Named Among Zero2IPO's Top 10 VC Firms of the Year; Nuro Closes Major Series D Round
Autonomous driving, healthcare, and chip sectors see new funding rounds; Genki Forest unveils "Triple Zero Factory" strategy; Dingdong Maicai stabilizes prices and ensures supply.
Mirxes Completes $87 Million Series C Round to Develop Early Cancer Screening Products Based on Leading miRNA Technology
Focused on microRNA technology, dedicated to early disease diagnosis.
